A$4.54
0.44%
Australia, Sep 25, 04:10 pm AEST. Closed.
ISIN
AU000000MPL3
Symbol
MPL
Index
Sector
Industry

Medibank Private Target price 2026 - Analyst rating & recommendation

Medibank Private Classifications & Recommendation

Buy
38%
Hold
62%

Medibank Private Price Target

Target Price A$5.15
Price A$4.54
Potential
Number of Estimates 9
9 Analysts have issued a price target Medibank Private 2027 . The average Medibank Private target price is A$5.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 5 Analysts recommend Medibank Private to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medibank Private stock has an average upside potential 2027 of . Most analysts recommend the Medibank Private stock at Hold.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Billion A$ 8.75 9.79
7.27% 11.88%
EBITDA Margin 11.85% 8.36%
16.86% 29.44%
Net Margin 7.30% 7.21%
18.90% 1.25%

6 Analysts have issued a sales forecast Medibank Private 2027 . The average Medibank Private sales estimate is

A$9.8b
unlock
. This is
11.88% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
A$10.3b 17.32%
unlock
, the lowest is
A$9.4b 7.11%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 A$8.7b 7.27%
2027
A$9.8b 11.88%
unlock
2028
A$10.3b 5.06%
unlock
2029
A$10.8b 4.77%
unlock

5 Analysts have issued an Medibank Private EBITDA forecast 2027. The average Medibank Private EBITDA estimate is

A$818m
unlock
. This is
21.05% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
A$851m 17.92%
unlock
, the lowest is
A$794m 23.39%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 A$1.0b 25.35%
2027
A$818m 21.05%
unlock
2028
A$924m 12.96%
unlock
2029
A$952m 3.04%
unlock

EBITDA Margin

2026 11.85% 16.86%
2027
8.36% 29.44%
unlock
2028
8.99% 7.54%
unlock
2029
8.84% 1.67%
unlock

10 Medibank Private Analysts have issued a net profit forecast 2027. The average Medibank Private net profit estimate is

A$706m
unlock
. This is
10.52% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
A$781m 22.24%
unlock
, the lowest is
A$664m 3.95%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 A$639m 27.54%
2027
A$706m 10.52%
unlock
2028
A$748m 5.95%
unlock
2029
A$787m 5.25%
unlock
2030
A$866m 10.00%
unlock
2031
A$891m 2.86%
unlock

Net Margin

2026 7.30% 18.90%
2027
7.21% 1.25%
unlock
2028
7.27% 0.83%
unlock
2029
7.31% 0.55%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share A$ 0.23 0.26
27.78% 13.04%
P/E 17.71
EV/Sales 1.25

10 Analysts have issued a Medibank Private forecast for earnings per share. The average Medibank Private EPS is

A$0.26
unlock
. This is
13.04% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
A$0.28 21.74%
unlock
, the lowest is
A$0.24 4.35%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 A$0.23 27.78%
2027
A$0.26 13.04%
unlock
2028
A$0.27 3.85%
unlock
2029
A$0.29 7.41%
unlock
2030
A$0.31 6.90%
unlock
2031
A$0.32 3.23%
unlock

P/E ratio

Current 19.74 27.34%
2027
17.71 10.28%
unlock
2028
16.72 5.59%
unlock
2029
15.88 5.02%
unlock
2030
14.44 9.07%
unlock
2031
14.04 2.77%
unlock

Based on analysts' sales estimates for 2027, the Medibank Private stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.40 10.83%
2027
1.25 10.51%
unlock
2028
1.19 4.82%
unlock
2029
1.14 4.55%
unlock

P/S ratio

Current 1.44 11.62%
2027
1.28 10.62%
unlock
2028
1.22 4.82%
unlock
2029
1.17 4.55%
unlock

Current Medibank Private Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
➜
Locked
Locked Sep 02 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Jul 09 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Jul 08 2026
JEFFERIES
Locked
➜
Locked
Locked May 05 2026
JEFFERIES
Locked
➜
Locked
Locked May 04 2026
JEFFERIES
Locked
➜
Locked
Locked Mar 02 2026
MACQUARIE RESEARCH
Locked
➜
Locked
Locked Feb 25 2026
Analyst Rating Date
Locked
JEFFERIES:
Locked
➜
Locked
Sep 02 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Jul 09 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Jul 08 2026
Locked
JEFFERIES:
Locked
➜
Locked
May 05 2026
Locked
JEFFERIES:
Locked
➜
Locked
May 04 2026
Locked
JEFFERIES:
Locked
➜
Locked
Mar 02 2026
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
Feb 25 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today